Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics

Microbial Pathogenesis

Volumn 81, Issue , 2015, Pages 46-52

  Li, Zhi Tao ^a   Zhang, Rui Ling ^a   Bi, Xiao Gang ^a   Xu, Lian ^b,c   Fan, Min ^a   Xie, Dan ^a   Xian, Ying ^a   Wang, Ying ^a   Li, Xiao Jie ^a   Wu, Zhong Dao ^b,c   Zhang, Kou Xing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Acinetobacter baumannii; Innate immunity; Outer membrane vesicles; Proteomics; Virulence

Indexed keywords

AMIDASE; AMINOPEPTIDASE; BACTERIAL PROTEIN; CHAPERONIN 60; EPSA PROTEIN; FILF PROTEIN; FOCAL ADHESION KINASE; GLUCOSE DEHYDROGENASE; HEMAGGLUTININ; HEMAGGLUTININ LIKE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 38; OUTER MEMBRANE PROTEIN H; PROTEIN TYROSINE KINASE; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERINE PROTEINASE; SUCCINATE DEHYDROGENASE; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEMBRANE VESICLE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSMISSION ELECTRON MICROSCOPY; ACINETOBACTER INFECTION; ANIMAL; CELL DEATH; CELL LINE; CHEMISTRY; EPITHELIUM CELL; ISOLATION AND PURIFICATION; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY; SECRETORY VESICLE; TANDEM MASS SPECTROMETRY;

ACINETOBACTER BAUMANNII; NEGIBACTERIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BACTERIAL PROTEINS; CELL DEATH; CELL LINE; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; HUMANS; MACROPHAGES; MICE; PROTEOME; SECRETORY VESICLES; TANDEM MASS SPECTROMETRY; VIRULENCE FACTORS;

EID: 84924990133     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2015.03.009     Document Type: Article

References (39)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21:538-582.
2. Doyle J.S., Buising K.L., Thursky K.A., Worth L.J., Richards M.J. Epidemiology of infections acquired in intensive care units. Semin. Respir. Crit. Care Med. 2011, 32:115-138.
3. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5:939-951.
4. Falagas M.E., Bliziotis I.A., Siempos I.I. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit. Care 2006, 10.
5. Zheng Y.L., Wan Y.F., Zhou L.Y., Ye M.L., Liu S., Xu C.Q., et al. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am. J. Infect. control 2013, 41:e59-63.
6. Chopra T., Marchaim D., Awali R.A., Krishna A., Johnson P., Tansek R., et al. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob. Agents Chemother. 2013, 57:6270-6275.
7. Huang S.T., Chiang M.C., Kuo S.C., Lee Y.T., Chiang T.H., Yang S.P., et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J.Microbiol. Immunol. Infect.= Wei mian yu gan ran za zhi 2012, 45:356-362.
8. Aydemir H., Celebi G., Piskin N., Oztoprak N., Keskin A.S., Aktas E., et al. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish University Hospital. Jpn. J. Infect. Dis. 2012, 65:66-71.
9. Wareham D.W., Bean D.C., Khanna P., Hennessy E.M., Krahe D., Ely A., et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur. J. Clin. Microbiol. Infect. Dis. - Off. Publ. Eur. Soc. Clin. Microbiol. 2008, 27:607-612.
10. Abbo A., Carmeli Y., Navon-Venezia S., Siegman-Igra Y., Schwaber M.J. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur. J. Clin. Microbiol. Infect. Dis. - Off. Publ. Eur. Soc. Clin. Microbiol. 2007, 26:793-800.
11. Breslow J.M., Meissler J.J., Hartzell R.R., Spence P.B., Truant A., Gaughan J., et al. Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect. Immun. 2011, 79:3317-3327.
12. Tayabali A.F., Nguyen K.C., Shwed P.S., Crosthwait J., Coleman G., Seligy V.L. Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources. PloS One 2012, 7:e37024.
13. Stathopoulos C., Hendrixson D.R., Thanassi D.G., Hultgren S.J., St Geme J.W., Curtiss R. Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story. Microbe. Infect./Inst. Pasteur 2000, 2:1061-1072.
14. McBroom A.J., Kuehn M.J. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 2007, 63:545-558.
15. Beveridge T.J., Kadurugamuwa J.L. Periplasm, periplasmic spaces, and their relation to bacterial wall structure: novel secretion of selected periplasmic proteins from Pseudomonas aeruginosa. Microb. Drug Resist. Larchmt. NY 1996, 2:1-8.
16. Mashburn-Warren L.M., Whiteley M. Special delivery: vesicle trafficking in prokaryotes. Mol. Microbiol. 2006, 61:839-846.
17. Kuehn M.J., Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 2005, 19:2645-2655.
18. Lee E.Y., Choi D.S., Kim K.P., Gho Y.S. Proteomics in Gram-negative bacterial outer membrane vesicles. Mass Spectrom. Rev. 2008, 27:535-555.
19. Beveridge T.J. Structures of gram-negative cell walls and their derived membrane vesicles. J.Bacteriol. 1999, 181:4725-4733.
20. Jun S.H., Lee J.H., Kim B.R., Kim S.I., Park T.I., Lee J.C., et al. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PloS One 2013, 8:e71751.
21. Ellis T.N., Leiman S.A., Kuehn M.J. Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect. Immun. 2010, 78:3822-3831.
22. Schaar V., de Vries S.P., Perez Vidakovics M.L., Bootsma H.J., Larsson L., Hermans P.W., et al. Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells. Cell. Microbiol. 2011, 13:432-449.
23. Wai S.N., Lindmark B., Soderblom T., Takade A., Westermark M., Oscarsson J., et al. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 2003, 115:25-35.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Kwon S.O., Gho Y.S., Lee J.C., Kim S.I. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol. Lett. 2009, 297:150-156.
26. Sheng W.H., Liao C.H., Lauderdale T.L., Ko W.C., Chen Y.S., Liu J.W., et al. Amulticenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int. J. Infect. Dis. - IJID - Off. Publ. Int. Soc. Infect. Dis. 2010, 14:e764-e769.
27. McConnell M.J., Actis L., Pachon J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 2013, 37:130-155.
28. Zhang H., Peterson J.W., Niesel D.W., Klimpel G.R. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J.Immunol. (Baltim. MD : 1950) 1997, 159:4868-4878.
29. Jin J.S., Kwon S.O., Moon D.C., Gurung M., Lee J.H., Kim S.I., et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PloS One 2011, 6:e17027.
30. Choi C.H., Hyun S.H., Lee J.Y., Lee J.S., Lee Y.S., Kim S.A., et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell. Microbiol. 2008, 10:309-319.
31. Lee J.S., Choi C.H., Kim J.W., Lee J.C. Acinetobacter baumannii outer membrane protein A induces dendritic cell death through mitochondrial targeting. J.Microbiol. (Seoul, Korea) 2010, 48:387-392.
32. Choi C.H., Lee E.Y., Lee Y.C., Park T.I., Kim H.J., Hyun S.H., et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell. Microbiol. 2005, 7:1127-1138.
33. Noah C.E., Malik M., Bublitz D.C., Camenares D., Sellati T.J., Benach J.L., et al. GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages. Infect. Immun. 2010, 78:1797-1806.
34. Russo T.A., Luke N.R., Beanan J.M., Olson R., Sauberan S.L., MacDonald U., et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 2010, 78:3993-4000.
35. Nishiyama T., Noguchi H., Yoshida H., Park S.Y., Tame J.R. The structure of the deacetylase domain of Escherichia coli PgaB, an enzyme required for biofilm formation: a circularly permuted member of the carbohydrate esterase 4 family. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2013, 69:44-51.
36. Darvish Alipour Astaneh S., Rasooli I., Mousavi Gargari S.L. The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606(T). Microb. Pathog. 2014, 74:42-49.
37. McQueary C.N., Actis L.A. Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J.Microbiol. (Seoul, Korea) 2011, 49:243-250.
38. Schaar V., Uddback I., Nordstrom T., Riesbeck K. Group A streptococci are protected from amoxicillin-mediated killing by vesicles containing beta-lactamase derived from Haemophilus influenzae. J.Antimicrob. Chemother. 2014, 69:117-120.
39. Schaar V., Nordstrom T., Morgelin M., Riesbeck K. Moraxella catarrhalis outer membrane vesicles carry beta-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob. Agents Chemother. 2011, 55:3845-3853.